3 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 3 |
| Phase 2 | 1 | Recruiting 1 |
Follow Insomnia: new trials by email Literature Review of Insomnia trials Research Report on Insomnia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098) Suvorexant, Placebo - Insomnia | Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 300 | 2025-10-09 | 2026-09-21 |
| Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer estazolam 1-2 mg, Auricular pressure bean combined with electroacupuncture - Cancer, Insomnia | Phase 3 | Recruiting | Qinghai Red Cross Hospital | 60 | 2025-03-01 | 2025-03-25 |
| Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia Melatonin, Quetiapine, Placebo - Psychiatric Disorders, Insomnia | Phase 2 / Phase 3 | Recruiting | Lone Baandrup | 255 | 2023-09-18 | 2025-04-24 |
Sleep Initiation and Maintenance Disorders (3) · Mental Disorders (1) · Neoplasms (1)
Dyssomnias (3) · Nervous System Diseases (3) · Sleep Disorders, Intrinsic (3) · Sleep Wake Disorders (3) · Mental Disorders (2)
Electroacupuncture (1) · Estazolam (1) · Melatonin (1) · Quetiapine Fumarate (1) · suvorexant (1)
Lone Baandrup (1) · Merck Sharp & Dohme LLC (1) · Qinghai Red Cross Hospital (1)
China (1) · Denmark (1) · United States (1)
2023 (1)